ARNALDI, DARIO
 Distribuzione geografica
Continente #
EU - Europa 16.134
AS - Asia 103
SA - Sud America 8
NA - Nord America 2
Totale 16.247
Nazione #
IT - Italia 16.133
CN - Cina 87
SG - Singapore 12
BR - Brasile 8
VN - Vietnam 4
US - Stati Uniti d'America 2
IE - Irlanda 1
Totale 16.247
Città #
Genova 7.240
Genoa 5.735
Vado Ligure 1.638
Rapallo 1.454
Bordighera 58
Beijing 32
Singapore 7
Rome 3
Turin 3
Ashburn 2
São Paulo 2
Campo Largo 1
Cunha 1
Curitiba 1
Cà Mau 1
Dublin 1
Haiphong 1
Ho Chi Minh City 1
Nova Petrópolis 1
Presidente Getúlio 1
Rio de Janeiro 1
Tây Ninh 1
Totale 16.185
Nome #
A normative study of the Italian printed word version of the free and cued selective reminding test 198
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 190
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 181
Neuroimaging findings in mild cognitive impairment 170
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 162
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 156
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 156
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 154
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 153
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 152
Parkinson’s Disease Sleep Scale 2: application in an Italian population 151
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 150
Brain Functional Network in Alzheimer’s Disease: Diagnostic Markers for Diagnosis and Monitoring 149
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 147
What predicts cognitive decline in de novo Parkinson's disease? 146
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 146
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 145
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 145
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. 144
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 142
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 142
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 142
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 142
Assessment of cognitive profile as a prodromal marker of the evolution of REM sleep Behavior Disorder 141
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 139
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 138
Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management 137
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. 136
A kinetics-based approach to amyloid PET semi-quantification 136
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 135
Early identification of MCI converting to AD: a FDG PET study 133
Does postural rigidity decrease during REM sleep without Atonia in Parkinson disease? 133
The role of the serotonergic system in REM sleep behavior disorder 132
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 131
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 130
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 129
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 129
Cortical Network Topology in Prodromal and Mild Dementia Due to Alzheimer’s Disease: Graph Theory Applied to Resting State EEG 129
Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson's disease 129
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 128
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 128
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 128
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 127
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 127
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 125
Functional imaging in pre-motor Parkinson's disease 125
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 122
Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts 122
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 122
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 122
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 121
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? 120
New tracers and new perspectives for molecular imaging in Lewy body diseases 120
Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker 119
Loss of REM sleep features across nighttime in REM sleep behavior disorder 117
The clinical relevance of cognitive impairment in REM sleep behavior disorder 117
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 117
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 115
Metabolic patterns across core features in dementia with lewy bodies 115
Direct correlation between cardiac and striatal F-18-DOPA uptake in de novo Parkinson's disease 114
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer's and Parkinson's diseases 114
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 114
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 113
Getting the high school diploma with only one hemisphere: a case report 113
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 113
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap 113
Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review. 112
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 112
Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder 112
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 110
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 110
The pharmacotherapeutic management of obstructive sleep apnea 108
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 108
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 107
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 107
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 105
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 102
The prognostic value of sleep patterns in disorders of consciousness in the sub-acute phase 102
Metabolic correlates of dopaminergic loss in dementia with lewy bodies 102
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 102
Neuroimaging Findings in Mild Cognitive Impairment 101
Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment 101
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 101
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 100
Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project 100
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 99
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 98
Probing the Role of a Regional Quantitative Assessment of Amyloid PET 97
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 96
Is dopamine transporter invariably impaired at the time of diagnosis in dementia with Lewy bodies? 95
Utility of quantitative EEG in early Lewy body disease 95
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 95
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 91
Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma 89
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences 89
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. 88
Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease 87
Lupus nephritis and Cyclic Vomiting Syndrome: a case report. 86
Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data 85
Epilepsy course during COVID-19 pandemic in three Italian epilepsy centers 84
Totale 12.307
Categoria #
all - tutte 64.959
article - articoli 60.293
book - libri 0
conference - conferenze 2.736
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.930
Totale 129.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.167 0 0 0 200 134 146 131 123 83 168 89 93
2021/20221.585 49 52 120 154 57 128 68 338 124 187 77 231
2022/20231.698 139 148 38 196 225 250 7 129 292 44 202 28
2023/20241.178 64 94 25 170 91 196 88 78 58 44 58 212
2024/20254.078 134 287 137 297 514 473 380 622 187 187 389 471
2025/20262.210 1.032 244 462 472 0 0 0 0 0 0 0 0
Totale 16.716